Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 25, 2019 08:30 ET | Source: Progenics Pharmaceuticals Inc.

Progenics Pharmaceuticals Announces Presentations at the Radiological Society of North America (RSNA) Annual Meeting

NEW YORK, Nov. 25, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative targeted medicines and artificial intelligence to find, fight and...
November 07, 2019 08:00 ET | Source: Progenics Pharmaceuticals Inc.

Progenics Pharmaceuticals Announces Business Update And Third Quarter 2019 Financial Results

Lantheus Holdings, Inc. to Acquire Progenics to Form an Innovative Commercial Life Sciences Company with a Diversified Portfolio of Precision Diagnostics and Radiopharmaceutical TherapeuticsAZEDRA...
November 01, 2019 13:00 ET | Source: Progenics Pharmaceuticals Inc.

Progenics Reminds Shareholders that November 17 is the Only Deadline for Velan’s Consent Solicitation

Notifies Shareholders that the S-4 Filing on the Value Maximizing Lantheus Transaction will be Filed with the SEC Before November 17 Shareholders Should Ignore Any Earlier Dates to Deliver Consents...
October 28, 2019 14:00 ET | Source: Progenics Pharmaceuticals Inc.

Progenics Strongly Agrees With ISS Recommendation that Velan Group SHOULD NOT Get Majority Control of the Board of Directors

ISS Recognizes that Shareholders Should Have Full Information About the Lantheus Transaction Before Making Significant Decisions About the Company Progenics Urges Shareholders to Protect the Value of...
October 21, 2019 08:46 ET | Source: Progenics Pharmaceuticals Inc.

Progenics Sends Letter to Shareholders

Calls Out Velan’s Pattern of Disregard for Good Corporate Governance and Business Ethics Reminds Shareholders to Sign and Return Progenics’ WHITE Consent Revocation Card NEW YORK, Oct. 21, 2019 ...